BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 26019277)

  • 41. A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15.
    Menzel S; Garner C; Gut I; Matsuda F; Yamaguchi M; Heath S; Foglio M; Zelenika D; Boland A; Rooks H; Best S; Spector TD; Farrall M; Lathrop M; Thein SL
    Nat Genet; 2007 Oct; 39(10):1197-9. PubMed ID: 17767159
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The E3 ligase adaptor molecule SPOP regulates fetal hemoglobin levels in adult erythroid cells.
    Lan X; Khandros E; Huang P; Peslak SA; Bhardwaj SK; Grevet JD; Abdulmalik O; Wang H; Keller CA; Giardine B; Baeza J; Duffner ER; El Demerdash O; Wu XS; Vakoc CR; Garcia BA; Hardison RC; Shi J; Blobel GA
    Blood Adv; 2019 May; 3(10):1586-1597. PubMed ID: 31126914
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fetal hemoglobin-boosting haplotypes of BCL11A gene and HBS1L-MYB intergenic region in the prediction of clinical and hematological outcomes in a cohort of children with sickle cell anemia.
    Sales RR; Nogueira BL; Belisário AR; Faria G; Mendes F; Viana MB; Luizon MR
    J Hum Genet; 2022 Dec; 67(12):701-709. PubMed ID: 36167770
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recent advances in globin research using genome-wide association studies and gene editing.
    Orkin SH
    Ann N Y Acad Sci; 2016 Mar; 1368(1):5-10. PubMed ID: 26866328
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pathogenic BCL11A variants provide insights into the mechanisms of human fetal hemoglobin silencing.
    Shen Y; Li R; Teichert K; Montbleau KE; Verboon JM; Voit RA; Sankaran VG
    PLoS Genet; 2021 Oct; 17(10):e1009835. PubMed ID: 34634037
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reduced rate of sickle-related complications in Brazilian patients carrying HbF-promoting alleles at the BCL11A and HMIP-2 loci.
    Leonardo FC; Brugnerotto AF; Domingos IF; Fertrin KY; de Albuquerque DM; Bezerra MA; Araújo AS; Saad ST; Costa FF; Menzel S; Conran N; Thein SL
    Br J Haematol; 2016 May; 173(3):456-60. PubMed ID: 26888013
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transcriptional regulators Myb and BCL11A interplay with DNA methyltransferase 1 in developmental silencing of embryonic and fetal β-like globin genes.
    Roosjen M; McColl B; Kao B; Gearing LJ; Blewitt ME; Vadolas J
    FASEB J; 2014 Apr; 28(4):1610-20. PubMed ID: 24371119
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Domain-focused CRISPR screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells.
    Grevet JD; Lan X; Hamagami N; Edwards CR; Sankaranarayanan L; Ji X; Bhardwaj SK; Face CJ; Posocco DF; Abdulmalik O; Keller CA; Giardine B; Sidoli S; Garcia BA; Chou ST; Liebhaber SA; Hardison RC; Shi J; Blobel GA
    Science; 2018 Jul; 361(6399):285-290. PubMed ID: 30026227
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regulation of the fetal hemoglobin silencing factor BCL11A.
    Basak A; Sankaran VG
    Ann N Y Acad Sci; 2016 Mar; 1368(1):25-30. PubMed ID: 26963603
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sustained fetal hemoglobin induction in vivo is achieved by
    Uchida N; Ferrara F; Drysdale CM; Yapundich M; Gamer J; Nassehi T; DiNicola J; Shibata Y; Wielgosz M; Kim YS; Bauler M; Throm RE; Haro-Mora JJ; Demirci S; Bonifacino AC; Krouse AE; Linde NS; Donahue RE; Ryu B; Tisdale JF
    Sci Transl Med; 2021 Apr; 13(591):. PubMed ID: 33910976
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The influence of the BCL11A polymorphism on the phenotype of patients with beta thalassemia could be affected by the beta globin locus control region and/or the Xmn1-HBG2 genotypic background.
    Neishabury M; Zamani F; Keyhani E; Azarkeivan A; Abedini SS; Eslami MS; Kakroodi ST; Vesiehsari MJ; Najmabadi H
    Blood Cells Mol Dis; 2013 Aug; 51(2):80-4. PubMed ID: 23541515
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Original Research: A case-control genome-wide association study identifies genetic modifiers of fetal hemoglobin in sickle cell disease.
    Liu L; Pertsemlidis A; Ding LH; Story MD; Steinberg MH; Sebastiani P; Hoppe C; Ballas SK; Pace BS
    Exp Biol Med (Maywood); 2016 Apr; 241(7):706-18. PubMed ID: 27022141
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hemoglobin switching's surprise: the versatile transcription factor BCL11A is a master repressor of fetal hemoglobin.
    Bauer DE; Orkin SH
    Curr Opin Genet Dev; 2015 Aug; 33():62-70. PubMed ID: 26375765
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hydroxyurea down-regulates BCL11A, KLF-1 and MYB through miRNA-mediated actions to induce γ-globin expression: implications for new therapeutic approaches of sickle cell disease.
    Pule GD; Mowla S; Novitzky N; Wonkam A
    Clin Transl Med; 2016 Mar; 5(1):15. PubMed ID: 27056246
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intermediaries of branched chain amino acid metabolism induce fetal hemoglobin, and repress SOX6 and BCL11A, in definitive erythroid cells.
    Karkashon S; Raghupathy R; Bhatia H; Dutta A; Hess S; Higgs J; Tifft CJ; Little JA
    Blood Cells Mol Dis; 2015 Aug; 55(2):161-7. PubMed ID: 26142333
    [TBL] [Abstract][Full Text] [Related]  

  • 56. KLF1 directly activates expression of the novel fetal globin repressor
    Norton LJ; Funnell APW; Burdach J; Wienert B; Kurita R; Nakamura Y; Philipsen S; Pearson RCM; Quinlan KGR; Crossley M
    Blood Adv; 2017 Apr; 1(11):685-692. PubMed ID: 29296711
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Brain malformations in a patient with deletion 2p16.1: A refinement of the phenotype to BCL11A.
    Balci TB; Sawyer SL; Davila J; Humphreys P; Dyment DA
    Eur J Med Genet; 2015; 58(6-7):351-4. PubMed ID: 25979662
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Strict in vivo specificity of the
    Smith EC; Luc S; Croney DM; Woodworth MB; Greig LC; Fujiwara Y; Nguyen M; Sher F; Macklis JD; Bauer DE; Orkin SH
    Blood; 2016 Nov; 128(19):2338-2342. PubMed ID: 27707736
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Common fetal hemoglobin variants in Lebanese patients bearing the codon 29 beta gene mutation associated with different thalassemia phenotypes.
    Brancaleoni V; Moukhadder HM; Consonni D; Koussa S; Di Pierro E; Cappellini MD; Taher A
    Ann Hematol; 2019 Apr; 98(4):833-840. PubMed ID: 30506348
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reawakening fetal hemoglobin: prospects for new therapies for the β-globin disorders.
    Bauer DE; Kamran SC; Orkin SH
    Blood; 2012 Oct; 120(15):2945-53. PubMed ID: 22904296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.